- Home
- UVV vs LENZ Comparison
UVV vs LENZ Comparison
Compare UVV & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVV
- LENZ
- Stock Information
- Founded
- UVV 1886
- LENZ 2019
- Country
- UVV United States
- LENZ United States
- Employees
- UVV N/A
- LENZ N/A
- Industry
- UVV Farming/Seeds/Milling
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- UVV Industrials
- LENZ Health Care
- Exchange
- UVV Nasdaq
- LENZ Nasdaq
- Market Cap
- UVV 1.3B
- LENZ 1.1B
- IPO Year
- UVV N/A
- LENZ 2021
- Fundamental
- Price
- UVV $56.83
- LENZ $42.20
- Analyst Decision
- UVV
- LENZ Strong Buy
- Analyst Count
- UVV 0
- LENZ 4
- Target Price
- UVV N/A
- LENZ $49.75
- AVG Volume (30 Days)
- UVV 187.0K
- LENZ 415.8K
- Earning Date
- UVV 08-06-2025
- LENZ 11-05-2025
- Dividend Yield
- UVV 5.92%
- LENZ N/A
- EPS Growth
- UVV N/A
- LENZ N/A
- EPS
- UVV 4.11
- LENZ N/A
- Revenue
- UVV $2,943,996,000.00
- LENZ $5,000,000.00
- Revenue This Year
- UVV $1.52
- LENZ N/A
- Revenue Next Year
- UVV $0.97
- LENZ $258.37
- P/E Ratio
- UVV $13.49
- LENZ N/A
- Revenue Growth
- UVV 4.11
- LENZ N/A
- 52 Week Low
- UVV $49.40
- LENZ $16.54
- 52 Week High
- UVV $67.33
- LENZ $42.77
- Technical
- Relative Strength Index (RSI)
- UVV 58.71
- LENZ 61.44
- Support Level
- UVV $54.71
- LENZ $39.62
- Resistance Level
- UVV $56.32
- LENZ $41.80
- Average True Range (ATR)
- UVV 0.98
- LENZ 1.94
- MACD
- UVV 0.10
- LENZ -0.04
- Stochastic Oscillator
- UVV 97.64
- LENZ 91.06
About UVV Universal Corporation
Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.